Citadel Advisors - MAGENTA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Citadel Advisors ownership history of MAGENTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,557,569
+10410.7%
3,374,101
+10919.3%
0.00%
Q1 2023$24,333
+63.7%
30,620
-18.6%
0.00%
Q4 2022$14,862
-73.5%
37,626
-6.5%
0.00%
Q3 2022$56,000
-86.2%
40,259
-71.2%
0.00%
Q1 2022$406,000
+728.6%
140,001
+1161.3%
0.00%
Q4 2021$49,000
-43.0%
11,100
-5.9%
0.00%
Q3 2021$86,000
-93.6%
11,800
-91.5%
0.00%
Q2 2021$1,352,000
-85.3%
138,267
-82.2%
0.00%
-100.0%
Q1 2021$9,181,000
+1063.6%
775,414
+670.6%
0.00%
Q4 2020$789,000
+55.9%
100,621
+35.1%
0.00%
Q3 2020$506,000
-22.2%
74,481
-14.0%
0.00%
Q2 2020$650,000
-5.2%
86,560
-20.8%
0.00%
Q1 2020$686,000
-48.5%
109,300
+24.4%
0.00%
-100.0%
Q4 2019$1,331,000
-28.1%
87,851
-51.3%
0.00%0.0%
Q3 2019$1,852,000
-45.2%
180,507
-21.2%
0.00%
-50.0%
Q2 2019$3,379,000
+17.8%
229,066
+31.5%
0.00%
+100.0%
Q1 2019$2,869,000
+2251.6%
174,219
+710.7%
0.00%
Q4 2018$122,000
-89.6%
21,491
-75.2%
0.00%
-100.0%
Q2 2018$1,172,00086,8050.00%
Other shareholders
MAGENTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP IV, LLC 8,008,204$50,292,00045.98%
Casdin Capital, LLC 2,971,034$18,658,0001.98%
Alphabet Inc. 3,339,138$20,970,0001.38%
Opaleye Management Inc. 434,712$2,730,0000.72%
Bleichroeder LP 251,875$1,582,0000.41%
Eventide Asset Management 1,789,646$11,239,0000.36%
HARVARD MANAGEMENT CO INC 332,610$2,089,0000.33%
GILDER GAGNON HOWE & CO LLC 4,059,789$25,495,0000.31%
Leap Investments LP 12,600$79,0000.12%
Aries Wealth Management 12,000$77,0000.06%
View complete list of MAGENTA THERAPEUTICS INC shareholders